OnKure Therapeutics Insider Trades
NASDAQ: OKURHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Last 12 months
- Purchases
- 0 · $0
- Sales
- 8 · $5.63K
- Shares bought / sold
- 0 / 1.55K
- Net activity
- Net selling $5,630
OnKure Therapeutics insider activity
Over the last 12 months, OnKure Therapeutics insiders reported 10 transactions on SEC Form 4: 0 open-market purchases and 8 sales. Insiders bought $0 and sold $5,630 worth of stock, for net insider selling of $5,630. The largest seller was Leverone Jason A., with $4,378 in reported sales.
The most recent filing shows Saccomano Nicholas A (President and CEO) selling 87 shares at $2.97 on Sep 21, 2026. Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put OKUR's ownership changes in context.
Summary generated from market data by MetaCap's automated system. Methodology
OKUR insider transactions
| Date | Insider | Type | Shares | Value | Filing |
|---|---|---|---|---|---|
| Sep 21, 2026 | Leverone Jason A.Chief Financial Officer | Sale | 302 | $898.21 | Form 4 |
| Sep 21, 2026 | Saccomano Nicholas APresident and CEO | Sale | 87 | $258.76 | Form 4 |
| Jun 22, 2026 | Leverone Jason A.Chief Financial Officer | Sale | 303 | $1.33K | Form 4 |
| Jun 22, 2026 | Saccomano Nicholas APresident and CEO | Sale | 86 | $378.08 | Form 4 |
| Mar 23, 2026 | Leverone Jason A.Chief Financial Officer | Sale | 301 | $1.25K | Form 4 |
| Mar 23, 2026 | Saccomano Nicholas APresident and CEO | Sale | 86 | $357.46 | Form 4 |
| Dec 31, 2025 | Mathers Edward TDirector | Award | 3,911 | — | Form 4 |
| Dec 31, 2025 | Manke IsaacDirector | Award | 5,258 | — | Form 4 |
| Dec 22, 2025 | Saccomano Nicholas APresident and CEO | Sale | 87 | $258.19 | Form 4 |
| Dec 22, 2025 | Leverone Jason A.Chief Financial Officer | Sale | 302 | $896.25 | Form 4 |
| Sep 30, 2025 | Manke IsaacDirector | Award | 5,545 | — | Form 4 |
| Sep 30, 2025 | Mathers Edward TDirector | Award | 4,125 | — | Form 4 |
| Sep 22, 2025 | Leverone Jason A.Chief Financial Officer | Sale | 303 | $794.92 | Form 4 |
| Sep 22, 2025 | Saccomano Nicholas APresident and CEO | Sale | 88 | $230.87 | Form 4 |
| Jun 30, 2025 | Manke IsaacDirector | Award | 6,311 | — | Form 4 |
| Jun 30, 2025 | Mathers Edward TDirector | Award | 4,694 | — | Form 4 |
| Jun 23, 2025 | Saccomano Nicholas APresident and CEO | Sale | 88 | $209.81 | Form 4 |
Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4